Jeffrey Varanelli, OD, FAAO
Researchers have shown that a novel eye drop can be used as a method of sustained delivery of antifibrotic drugs in patients with fibrosis associated with bacterial keratitis, according to a study published in npj Regenerative Medicine.
“We believe that this drug delivery system is an ideal noninvasive antifibrotic treatment for patients with microbial keratitis, potentially without recourse to surgery, saving the sight of many in the developing world, where corneal transplantation may not be available,” the authors wrote.
This activity is supported by an educational grant from Genentech, Inc.
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.